
Reviva Pharmaceuticals Holdings, Inc. – NASDAQ:RVPH
Reviva Pharmaceuticals Holdings stock price today
Reviva Pharmaceuticals Holdings stock price monthly change
Reviva Pharmaceuticals Holdings stock price quarterly change
Reviva Pharmaceuticals Holdings stock price yearly change
Reviva Pharmaceuticals Holdings key metrics
Market Cap | 58.45M |
Enterprise value | N/A |
P/E | -3.58 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 7.14 |
PEG ratio | 0.04 |
EPS | -1.71 |
Revenue | N/A |
EBITDA | -36.49M |
Income | -37.65M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeReviva Pharmaceuticals Holdings stock price history
Reviva Pharmaceuticals Holdings stock forecast
Reviva Pharmaceuticals Holdings financial statements
Dec 2022 | 0 | -8.11M | |
---|---|---|---|
Mar 2023 | 0 | -6.60M | |
Jun 2023 | 0 | -12.44M | |
Sep 2023 | 0 | -10.49M |
Jun 2023 | 0 | -12.44M | |
---|---|---|---|
Sep 2023 | 0 | -10.49M | |
Sep 2025 | 0 | -5.84M | |
Dec 2025 | 0 | -5.60M |
Analysts Price target
Financials & Ratios estimates
Dec 2022 | 18923675 | 6.60M | 34.92% |
---|---|---|---|
Mar 2023 | 12901523 | 7.11M | 55.16% |
Jun 2023 | 11842022 | 10.22M | 86.31% |
Sep 2023 | 5387041 | 13.90M | 258.15% |
Sep 2022 | -4.00M | 0 | 7.77M |
---|---|---|---|
Dec 2022 | -4.69M | 0 | 18.56K |
Mar 2023 | -7.95M | 0 | 687.09K |
Jun 2023 | -5.31M | 0 | 5.21M |
Reviva Pharmaceuticals Holdings alternative data
Aug 2023 | 10 |
---|---|
Sep 2023 | 10 |
Oct 2023 | 10 |
Nov 2023 | 10 |
Dec 2023 | 10 |
Jan 2024 | 10 |
Feb 2024 | 10 |
Mar 2024 | 10 |
Apr 2024 | 10 |
May 2024 | 15 |
Jun 2024 | 15 |
Jul 2024 | 15 |
Reviva Pharmaceuticals Holdings other data
Period | Buy | Sel |
---|---|---|
Jun 2022 | 50000 | 0 |
Sep 2022 | 50000 | 0 |
Nov 2022 | 3000 | 0 |
Insider | Compensation |
---|---|
Dr. Laxminarayan Bhat Ph.D. (1965) Founder, Chief Executive Officer, Pres & Director | $247,950 |
-
What's the price of Reviva Pharmaceuticals Holdings stock today?
One share of Reviva Pharmaceuticals Holdings stock can currently be purchased for approximately $0.53.
-
When is Reviva Pharmaceuticals Holdings's next earnings date?
Unfortunately, Reviva Pharmaceuticals Holdings's (RVPH) next earnings date is currently unknown.
-
Does Reviva Pharmaceuticals Holdings pay dividends?
No, Reviva Pharmaceuticals Holdings does not pay dividends.
-
How much money does Reviva Pharmaceuticals Holdings make?
Reviva Pharmaceuticals Holdings has a market capitalization of 58.45M.
-
What is Reviva Pharmaceuticals Holdings's stock symbol?
Reviva Pharmaceuticals Holdings, Inc. is traded on the NASDAQ under the ticker symbol "RVPH".
-
What is Reviva Pharmaceuticals Holdings's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Reviva Pharmaceuticals Holdings?
Shares of Reviva Pharmaceuticals Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Reviva Pharmaceuticals Holdings's key executives?
Reviva Pharmaceuticals Holdings's management team includes the following people:
- Dr. Laxminarayan Bhat Ph.D. Founder, Chief Executive Officer, Pres & Director(age: 60, pay: $247,950)
-
Is Reviva Pharmaceuticals Holdings founder-led company?
Yes, Reviva Pharmaceuticals Holdings is a company led by its founder Dr. Laxminarayan Bhat Ph.D..
-
How many employees does Reviva Pharmaceuticals Holdings have?
As Jul 2024, Reviva Pharmaceuticals Holdings employs 15 workers, which is 50% more then previous quarter.
-
When Reviva Pharmaceuticals Holdings went public?
Reviva Pharmaceuticals Holdings, Inc. is publicly traded company for more then 6 years since IPO on 18 Oct 2018.
-
What is Reviva Pharmaceuticals Holdings's official website?
The official website for Reviva Pharmaceuticals Holdings is revivapharma.com.
-
Where are Reviva Pharmaceuticals Holdings's headquarters?
Reviva Pharmaceuticals Holdings is headquartered at 19925 Stevens Creek Boulevard, Cupertino, CA.
-
How can i contact Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings's mailing address is 19925 Stevens Creek Boulevard, Cupertino, CA and company can be reached via phone at +40 85018881.
Reviva Pharmaceuticals Holdings company profile:

Reviva Pharmaceuticals Holdings, Inc.
revivapharma.comNASDAQ
15
Biotechnology
Healthcare
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.
Cupertino, CA 95014
CIK: 0001742927
ISIN: US76152G1004
CUSIP: 76152G100